In Vivo or in Vitro Method For Detecting Amyloid Deposits Having at Least One Amyloidogenic Protein
AssigneeUniversity of Pittsburgh
InventorWilliam E. Klunk
Life of this patent
Estimating the term…
Abstract
An amyloid deposit can be detected by administering to a subject or applying to a sample a compound of Formula (I) or Formula (II) or structures 1-45, as described, and then imaging to detect binding of the compound to an amyloid deposit, where the amyloido genie protein of the deposit can be AL, AH, ATTR, Aβ2M, AA, AApoAI, AApoAII, AGeI, ALys, AFib, ACys, ABri, ADan, APrP, ACaI, AlAPP, AANF, APro, AIns, AMed, AKer, A(tbn), and/or ALac.
Claims24
An in vivo method for detecting in a subject at least one amyloid deposit comprising at least one amyloidogenic protein, comprising the steps of:
- (a) administering to a subject suffering from a disease associated with amyloidosis, a detectable quantity of a pharmaceutical composition comprising at least one compound of formula I and a pharmaceutically acceptable carrier,
- wherein
- (i) Z is S, NR′, O or C(R′)2, such that when Z is C(R′)2, the tautomeric form of the heterocyclic ring may form an indole:
- wherein R′ is H or a lower alkyl group,
- (ii) Y is NR1R2, OR2, or SR2,
- (iii) R1 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (iv) R2 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (v) R3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vi) R4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vii) R5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (viii) R6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (ix) R7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (x) R8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xi) R9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xii) R10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- alternatively, one of R3-R10 may be a chelating group, with or without a chelated metal group, said chelating group being of the form W-L or V-W-L, wherein V is selected from the group consisting of —COO—, —CO—, —CH2O— and —CH2NH—;
- W is —(CH2)n where n=0, 1, 2, 3, 4, or 5, and L is:
- wherein M is selected from the group consisting of Tc and Re and radiolabelled derivatives and pharmaceutically acceptable salts thereof, where at least one of the substituent moieties comprises a detectable label;
- and
- (b) detecting the binding of the compound to an amyloid deposit comprising at least one amyloidogenic protein, wherein the amyloidogenic protein is selected from the group consisting of AL, AH, ATTR, Aβ2M, AA, AApoAI, AApoAII, AGel, ALys, AFib, ACys, ABri, ADan, APrP, ACal, AlAPP, AANF, APro, AIns, AMed, AKer, A(tbn), and ALac.
An in vitro method for detecting in a subject at least one amyloid deposit comprising at least one amyloidogenic protein, comprising the steps of
- (a) obtaining a fresh or frozen tissue specimen and incubating a section of the tissue or a homogenate of the tissue with a radioactively labeled thioflavin derivative of formula (I):
- formula I and a pharmaceutically acceptable carrier,
- wherein
- (i) Z is S, NR′, O or C(R′)2, such that when Z is C(R′)2, the tautomeric form of the heterocyclic ring may form an indole:
- wherein R′ is H or a lower alkyl group,
- (ii) Y is NR1R2, OR2, or SR2,
- (iii) R1 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (iv) R2 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (v) R3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vi) R4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vii) R5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (viii) R6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (ix) R7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (x) R8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xi) R9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xii) R10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- alternatively, one of R3-R10 may be a chelating group, with or without a chelated metal group, said chelating group being of the form W-L or V-W-L, wherein V is selected from the group consisting of —COO—, —CO—, —CH2O— and —CH2NH—;
- W is —(CH2)n where n=0, 1, 2, 3, 4, or 5, and L is:
- wherein M is selected from the group consisting of Tc and Re and radiolabelled derivatives and pharmaceutically acceptable salts thereof,
- where at least one of the substituent moieties comprises a detectable label;
- (b) then separating bound and free radiolabel by washing the tissue section or filtering and washing the tissue homogenate;
- and
- (c) detecting the binding of the compound to an amyloid deposit comprising at least one amyloidogenic protein, wherein the amyloidogenic protein is selected from the group consisting of AL, AH, ATTR, Aβ2M, AA, AApoAI, AApoAII, AGel, ALys, AFib, ACys, ABri, ADan, APrP, ACal, AlAPP, AANF, APro, AIns, AMed, AKer, A(tbn), and ALac.
An in vivo method for detecting in a subject at least one amyloid deposit comprising at least one amyloidogenic protein, comprising the steps of:
- (a) administering to a subject suffering from a disease associated with amyloidosis, a detectable quantity of a pharmaceutical composition comprising at least one compound of formula I and a pharmaceutically acceptable carrier,
- wherein
- (i) Z is S, NR′, O or C(R′)2, such that when Z is C(R′)2, the tautomeric form of the heterocyclic ring may form an indole:
- wherein R′ is H or a lower alkyl group,
- (ii) Y is NR1R2, OR2, or SR2,
- (iii) R1 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R1 is H or a lower alkyl group);
- (iv) R2 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (v) R3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vi) R4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vii) R5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (viii) R6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (ix) R7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (x) R8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xi) R9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xii) R10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- alternatively, one of R3-R10 may be a chelating group, with or without a chelated metal group, said chelating group being of the form W-L or V-W-L, wherein V is selected from the group consisting of —COO—, —CO—, —CH2O— and —CH2NH—;
- W is —(CH2)n where n=0, 1, 2, 3, 4, or 5, and L is:
- wherein M is selected from the group consisting of Tc and Re and radiolabelled derivatives and pharmaceutically acceptable salts thereof, where at least one of the substituent moieties comprises a detectable label,
- whereby the compound binds to the amyloid deposit comprising at least one amyloidogenic protein, wherein the amyloidogenic protein is selected from the group consisting of AL, AH, ATTR, Aβ2M, AA, AApoAI, AApoAII, AGel, ALys, AFib, ACys, ABri, ADan, APrP, ACal, AlAPP, AANF, APro, AIns, AMed, AKer, A(tbn), and ALac;
- (b) irradiating the subject and collecting imaging data emitted by the compound;
- and
- (c) processing the imaging data.
Use of a compound according to formula (I):
- wherein
- (i) Z is S, NR′, O or C(R′)2, such that when Z is C(R′)2, the tautomeric form of the heterocyclic ring may form an indole:
- wherein R′ is H or a lower alkyl group,
- (ii) Y is NR1R2, OR2, or SR2,
- (iii) R1 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (iv) R2 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (v) R3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vi) R4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n−1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vii) R5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (viii) R6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (ix) R7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (x) R8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xi) R9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xii) R10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- alternatively, one of R3-R10 may be a chelating group, with or without a chelated metal group, said chelating group being of the form W-L or V-W-L, wherein V is selected from the group consisting of —COO—, —CO—, —CH2O— and —CH2NH—;
- W is —(CH2)n where n=0, 1, 2, 3, 4, or 5, and L is:
- wherein M is selected from the group consisting of Tc and Re and radiolabelled derivatives and pharmaceutically acceptable salts thereof, where at least one of the substituent moieties comprises a detectable label,
- for the detection of at least one amyloid deposit in a subject suffering from a disease associated with amyloidosis.
Use of a compound according to formula (I):
- wherein
- (i) Z is S, NR′, O or C(R′)2, such that when Z is C(R′)2, the tautomeric form of the heterocyclic ring may form an indole:
- wherein R′ is H or a lower alkyl group,
- (ii) Y is NR1R2, OR2, or SR2,
- (iii) R′ is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (iv) R2 is selected from the group consisting of H, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, CH2—CH2—CH2X (wherein X═F, Cl, Br or I), (C═O)—R′, Rph, and (CH2)nRph (wherein n=1, 2, 3, or 4 and Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′ and COOR′, where R′ is H or a lower alkyl group);
- (v) R3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vi) R4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (vii) R5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (viii) R6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (ix) R7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (x) R8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xi) R9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- (xii) R10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, Rph, CR′═CR′—Rph, CR2′—CR2′—Rph (wherein Rph represents an unsubstituted or substituted phenyl group with the phenyl substituents being chosen from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH2)nOR′ (wherein n=1, 2, or 3), CF3, CH2—CH2X, O—CH2—CH2X, CH2—CH2—CH2X, O—CH2—CH2—CH2X (wherein X═F, Cl, Br or I), CN, (C═O)—R′, N(R′)2, NO2, (C═O)N(R′)2, O(CO)R′, OR′, SR′, COOR′, where R′ is H or a lower alkyl group) and a tri-alkyl tin;
- alternatively, one of R3-R10 may be a chelating group, with or without a chelated metal group, said chelating group being of the form W-L or V-W-L, wherein V is selected from the group consisting of —COO—, —CO—, —CH2O— and —CH2NH—;
- W is —(CH2)n where n=0, 1, 2, 3, 4, or 5, and L is:
- wherein M is selected from the group consisting of Tc and Re and radiolabelled derivatives and pharmaceutically acceptable salts thereof, where at least one of the substituent moieties comprises a detectable label,
- in the preparation of a medicament for use in the detection of at least one amyloid deposit in a subject suffering from a disease associated with amyloidosis.
Dependencies are inferred from the claim text.